Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00171041 · ClinicalTrials.gov registry record · Phase 3
A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 265
- Enrollment target
NCT00171041 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 265 participants.
The verdict
NCT00171041, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 265 participants
- Enrollment target
Study Summary
Drugs used to treat high blood pressure in adults should also be effective in treating high blood pressure in children and adolescents. This study will test the safety and efficacy of valsartan in treating high blood pressure in hypertensive children 6-16 years of age whose parent(s)/guardian(s) grant permission to participate.
Interventions
- DRUG valsartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2002-12 |
| Est. Completion | 2006-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00171041
The ClinicalTrials.gov registry entry for NCT00171041 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which valsartan is the first listed.
NCT00171041 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00171041 about?
NCT00171041 is a clinical study titled "A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age". Drugs used to treat high blood pressure in adults should also be effective in treating high blood pressure in children and adolescents. This study will test the safety and efficacy of valsartan in treating high blood pressure in hypertensive children 6-16 years of age whose parent(s)/guardian(s) gra...
What is the current status of trial NCT00171041?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 265 participants. The study started on 2002-12. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00171041?
The interventions under investigation include: valsartan (DRUG).
Who is sponsoring clinical trial NCT00171041?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.